The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 07, 2015
Filed:
Aug. 06, 2013
Applicants:
Steffan Nawrocki, San Antonio, TX (US);
Jennifer Carew, San Antonio, TX (US);
Guru Reddy, Irvine, CA (US);
Inventors:
Steffan Nawrocki, San Antonio, TX (US);
Jennifer Carew, San Antonio, TX (US);
Guru Reddy, Irvine, CA (US);
Assignee:
Spectrum Pharmaceuticals, Inc., Irvine, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/38 (2006.01); A61K 31/00 (2006.01); A61K 31/138 (2006.01); A61K 31/165 (2006.01); A61K 31/166 (2006.01); A61K 31/167 (2006.01); A61K 31/18 (2006.01); A61K 31/19 (2006.01); A61K 31/222 (2006.01); A61K 31/27 (2006.01); A61K 31/337 (2006.01); A61K 31/343 (2006.01); A61K 31/382 (2006.01); A61K 31/39 (2006.01); A61K 31/404 (2006.01); A61K 31/4045 (2006.01); A61K 31/4188 (2006.01); A61K 31/427 (2006.01); A61K 31/435 (2006.01); A61K 31/436 (2006.01); A61K 31/4406 (2006.01); A61K 31/4545 (2006.01); A61K 31/4706 (2006.01); A61K 31/495 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/69 (2006.01); A61K 31/7004 (2006.01); A61K 31/7048 (2006.01); A61K 33/36 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/27 (2013.01); A61K 31/00 (2013.01); A61K 31/138 (2013.01); A61K 31/165 (2013.01); A61K 31/166 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/19 (2013.01); A61K 31/222 (2013.01); A61K 31/337 (2013.01); A61K 31/343 (2013.01); A61K 31/382 (2013.01); A61K 31/39 (2013.01); A61K 31/404 (2013.01); A61K 31/4045 (2013.01); A61K 31/4188 (2013.01); A61K 31/427 (2013.01); A61K 31/435 (2013.01); A61K 31/436 (2013.01); A61K 31/4406 (2013.01); A61K 31/4545 (2013.01); A61K 31/4706 (2013.01); A61K 31/495 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/69 (2013.01); A61K 31/7004 (2013.01); A61K 31/7048 (2013.01); A61K 33/36 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present specification provides compositions comprising a thioxanthone-based autophagy inhibitor and/or a cancer therapeutic autophagy inducing compound, pharmaceutical kits comprising these compositions, and methods of treating cancer using such compounds, compositions and kits. Additionally, the present specification provides methods of treating cancer using a thioxanthone-based autophagy inhibitor and a radiotherapy.